Depression is a mental health issue. It's a condition that starts most often in early adulthood. It's also more common in women. However, anyone at any age may suffer from depression. Depression affects the brain, so drugs that work in the brain may offer hope. Common antidepressants may help ease your symptoms, but there are many other options as well. Each drug used to treat depression works by balancing certain chemicals in your brain called neurotransmitters. Depression Drugs is drugs used for Depression.
This report contains market size and forecasts of Depression Drugs in China, including the following market information:
China Depression Drugs Market Revenue, 2015-2020, 2021-2026, ($ millions)
Top Five Competitors in China Depression Drugs Market 2019 (%)
The global Depression Drugs market was valued at 16380 million in 2019 and is projected to reach US$ 18280 million by 2026, at a CAGR of 2.8% during the forecast period. While the Depression Drugs market size in China was US$ XX million in 2019, and it is expected to reach US$ XX million by the end of 2026, with a CAGR of XX% during 2020-2026.
COVID-19 pandemic has big impact on Depression Drugs businesses, with lots of challenges and uncertainty faced by many players of Depression Drugs in China. This report also analyses and evaluates the COVID-19 impact on Depression Drugs market size in 2020 and the next few years in China
Total Market by Segment:
China Depression Drugs Market, By Type, 2015-2020, 2021-2026 ($ millions)
China Depression Drugs Market Segment Percentages, By Type, 2019 (%)
- SSRIs
- SNRIs
- Others
China Depression Drugs Market, By Application, 2015-2020, 2021-2026 ($ millions)
China Depression Drugs Market Segment Percentages, By Application, 2019 (%)
- Hospitals
- Clinics
- Others
Competitor Analysis
The report also provides analysis of leading market participants including:
Total Depression Drugs Market Competitors Revenues in China, by Players 2015-2020 (Estimated), ($ millions)
Total Depression Drugs Market Competitors Revenues Share in China, by Players 2019 (%)
Further, the report presents profiles of competitors in the market, including the following:
- Intellipharmaceutics
- Pfizer
- Eli Lilly
- Astrazeneca
- Lundbeck
- Allergan
- GSK
- Otsuka Pharmaceutical
- Takeda
- NHU Group
- Shionogi
- APOTEX
- Kanghong Pharma
Depression Drugs Market in China - Industry Outlook and Forecast 2020-2026
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Depression Drugs Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 COVID-19 Impact: China Depression Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 China Depression Drugs Overall Market Size
2.1 China Depression Drugs Market Size: 2020 VS 2026
2.2 China Depression Drugs Revenue, Prospects & Forecasts: 2015-2026
3 Company Landscape
3.1 Top Depression Drugs Players in China (including Foreign and Local Companies)
3.2 Top China Depression Drugs Companies Ranked by Revenue
3.3 China Depression Drugs Revenue by Companies (including Foreign and Local Companies)
3.4 Top 3 and Top 5 Depression Drugs Companies in China, by Revenue in 2019
3.5 China Manufacturers Depression Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Depression Drugs Players in China
3.6.1 List of China Tier 1 Depression Drugs Companies
3.6.2 List of China Tier 2 and Tier 3 Depression Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - China Depression Drugs Market Size Markets, 2020 & 2026
4.1.2 SSRIs
4.1.3 SNRIs
4.1.4 Others
4.2 By Type - China Depression Drugs Revenue & Forecasts
4.2.1 By Type - China Depression Drugs Revenue, 2015-2020
4.2.2 By Type - China Depression Drugs Revenue, 2021-2026
4.2.3 By Type - China Depression Drugs Revenue Market Share, 2015-2026
5 Sights by Application
5.1 Overview
5.1.1 By Application - China Depression Drugs Market Size, 2020 & 2026
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application - China Depression Drugs Revenue & Forecasts
5.2.1 By Application - China Depression Drugs Revenue, 2015-2020
5.2.2 By Application - China Depression Drugs Revenue, 2021-2026
5.2.3 By Application - China Depression Drugs Revenue Market Share, 2015-2026
6 Players Profiles
6.1 Intellipharmaceutics
6.1.1 Intellipharmaceutics Corporate Summary
6.1.2 Intellipharmaceutics Business Overview
6.1.3 Intellipharmaceutics Depression Drugs Major Product Offerings
6.1.4 Intellipharmaceutics Revenue in China (2015-2020)
6.1.5 Intellipharmaceutics Key News
6.2 Pfizer
6.2.1 Pfizer Corporate Summary
6.2.2 Pfizer Business Overview
6.2.3 Pfizer Depression Drugs Major Product Offerings
6.2.4 Pfizer Revenue in China (2015-2020)
6.2.5 Pfizer Key News
6.3 Eli Lilly
6.3.1 Eli Lilly Corporate Summary
6.3.2 Eli Lilly Business Overview
6.3.3 Eli Lilly Depression Drugs Major Product Offerings
6.3.4 Eli Lilly Revenue in China (2015-2020)
6.3.5 Eli Lilly Key News
6.4 Astrazeneca
6.4.1 Astrazeneca Corporate Summary
6.4.2 Astrazeneca Business Overview
6.4.3 Astrazeneca Depression Drugs Major Product Offerings
6.4.4 Astrazeneca Revenue in China (2015-2020)
6.4.5 Astrazeneca Key News
6.5 Lundbeck
6.5.1 Lundbeck Corporate Summary
6.5.2 Lundbeck Business Overview
6.5.3 Lundbeck Depression Drugs Major Product Offerings
6.5.4 Lundbeck Revenue in China (2015-2020)
6.5.5 Lundbeck Key News
6.6 Allergan
6.6.1 Allergan Corporate Summary
6.6.2 Allergan Business Overview
6.6.3 Allergan Depression Drugs Major Product Offerings
6.6.4 Allergan Revenue in China (2015-2020)
6.6.5 Allergan Key News
6.7 GSK
6.6.1 GSK Corporate Summary
6.6.2 GSK Business Overview
6.6.3 GSK Depression Drugs Major Product Offerings
6.4.4 GSK Revenue in China (2015-2020)
6.7.5 GSK Key News
6.8 Otsuka Pharmaceutical
6.8.1 Otsuka Pharmaceutical Corporate Summary
6.8.2 Otsuka Pharmaceutical Business Overview
6.8.3 Otsuka Pharmaceutical Depression Drugs Major Product Offerings
6.8.4 Otsuka Pharmaceutical Revenue in China (2015-2020)
6.8.5 Otsuka Pharmaceutical Key News
6.9 Takeda
6.9.1 Takeda Corporate Summary
6.9.2 Takeda Business Overview
6.9.3 Takeda Depression Drugs Major Product Offerings
6.9.4 Takeda Revenue in China (2015-2020)
6.9.5 Takeda Key News
6.10 NHU Group
6.10.1 NHU Group Corporate Summary
6.10.2 NHU Group Business Overview
6.10.3 NHU Group Depression Drugs Major Product Offerings
6.10.4 NHU Group Revenue in China (2015-2020)
6.10.5 NHU Group Key News
6.11 Shionogi
6.11.1 Shionogi Corporate Summary
6.11.2 Shionogi Depression Drugs Business Overview
6.11.3 Shionogi Depression Drugs Major Product Offerings
6.11.4 Shionogi Revenue in China (2015-2020)
6.11.5 Shionogi Key News
6.12 APOTEX
6.12.1 APOTEX Corporate Summary
6.12.2 APOTEX Depression Drugs Business Overview
6.12.3 APOTEX Depression Drugs Major Product Offerings
6.12.4 APOTEX Revenue in China (2015-2020)
6.12.5 APOTEX Key News
6.13 Kanghong Pharma
6.13.1 Kanghong Pharma Corporate Summary
6.13.2 Kanghong Pharma Depression Drugs Business Overview
6.13.3 Kanghong Pharma Depression Drugs Major Product Offerings
6.13.4 Kanghong Pharma Revenue in China (2015-2020)
6.13.5 Kanghong Pharma Key News
6.14 HUAHAI
6.14.1 HUAHAI Corporate Summary
6.14.2 HUAHAI Depression Drugs Business Overview
6.14.3 HUAHAI Depression Drugs Major Product Offerings
6.14.4 HUAHAI Revenue in China (2015-2020)
6.14.5 HUAHAI Key News
7 Key Market Trends & Influences 2021-2026
7.1 PESTLE Analysis for China Depression Drugs Market
7.2 Market Opportunities & Trends
7.3 Market Drivers
7.4 Market Restraints
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Key Players of Depression Drugs in China
Table 2. Top Players in China, Ranking by Revenue (2019)
Table 3. China Depression Drugs Revenue by Companies, (US$, Mn), 2015-2020
Table 4. China Depression Drugs Revenue Share by Companies, 2015-2020
Table 5. China Depression Drugs Sales by Companies, (K Units), 2015-2020
Table 6. China Depression Drugs Sales Share by Companies, 2015-2020
Table 7. Key Manufacturers Depression Drugs Price (2015-2020) (US$/Unit)
Table 8. China Manufacturers Depression Drugs Product Type
Table 9. List of China Tier 1 Depression Drugs Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 10. List of China Tier 2 and Tier 3 Depression Drugs Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 11. By Type - Depression Drugs Revenue in China (US$, Mn), 2015-2020
Table 12. By Type - Depression Drugs Revenue in China (US$, Mn), 2021-2026
Table 13. By Type - Depression Drugs Sales in China (K Units), 2015-2020
Table 14. By Type - Depression Drugs Sales in China (K Units), 2021-2026
Table 15. By Application - Depression Drugs Revenue in China, (US$, Mn), 2015-2020
Table 16. By Application - Depression Drugs Revenue in China, (US$, Mn), 2021-2026
Table 17. By Application - Depression Drugs Sales in China, (K Units), 2015-2020
Table 18. By Application - Depression Drugs Sales in China, (K Units), 2021-2026
Table 19. Intellipharmaceutics Corporate Summary
Table 20. Intellipharmaceutics Depression Drugs Product Offerings
Table 21. Intellipharmaceutics Depression Drugs Revenue (US$, Mn), (2015-2020)
Table 22. Pfizer Corporate Summary
Table 23. Pfizer Depression Drugs Product Offerings
Table 24. Pfizer Depression Drugs Revenue (US$, Mn), (2015-2020)
Table 25. Eli Lilly Corporate Summary
Table 26. Eli Lilly Depression Drugs Product Offerings
Table 27. Eli Lilly Depression Drugs Revenue (US$, Mn), (2015-2020)
Table 28. Astrazeneca Corporate Summary
Table 29. Astrazeneca Depression Drugs Product Offerings
Table 30. Astrazeneca Depression Drugs Revenue (US$, Mn), (2015-2020)
Table 31. Lundbeck Corporate Summary
Table 32. Lundbeck Depression Drugs Product Offerings
Table 33. Lundbeck Depression Drugs Revenue (US$, Mn), (2015-2020)
Table 34. Allergan Corporate Summary
Table 35. Allergan Depression Drugs Product Offerings
Table 36. Allergan Depression Drugs Revenue (US$, Mn), (2015-2020)
Table 37. GSK Corporate Summary
Table 38. GSK Depression Drugs Product Offerings
Table 39. GSK Depression Drugs Revenue (US$, Mn), (2015-2020)
Table 40. Otsuka Pharmaceutical Corporate Summary
Table 41. Otsuka Pharmaceutical Depression Drugs Product Offerings
Table 42. Otsuka Pharmaceutical Depression Drugs Revenue (US$, Mn), (2015-2020)
Table 43. Takeda Corporate Summary
Table 44. Takeda Depression Drugs Product Offerings
Table 45. Takeda Depression Drugs Revenue (US$, Mn), (2015-2020)
Table 46. NHU Group Corporate Summary
Table 47. NHU Group Depression Drugs Product Offerings
Table 48. NHU Group Depression Drugs Revenue (US$, Mn), (2015-2020)
Table 49. Shionogi Corporate Summary
Table 50. Shionogi Depression Drugs Product Offerings
Table 51. Shionogi Depression Drugs Revenue (US$, Mn), (2015-2020)
Table 52. APOTEX Corporate Summary
Table 53. APOTEX Depression Drugs Product Offerings
Table 54. APOTEX Depression Drugs Revenue (US$, Mn), (2015-2020)
Table 55. Kanghong Pharma Corporate Summary
Table 56. Kanghong Pharma Depression Drugs Product Offerings
Table 57. Kanghong Pharma Depression Drugs Revenue (US$, Mn), (2015-2020)
Table 58. HUAHAI Corporate Summary
Table 59. HUAHAI Depression Drugs Product Offerings
Table 60. HUAHAI Depression Drugs Revenue (US$, Mn), (2015-2020)
List of Figures
Figure 1. Depression Drugs Segment by Type
Figure 2. Depression Drugs Segment by Application
Figure 3. China Depression Drugs Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Depression Drugs Market Size in China, (US$, Mn): 2020 VS 2026
Figure 6. China Depression Drugs Revenue, 2015-2026 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Depression Drugs Revenue in 2019
Figure 8. By Type - China Depression Drugs Incremental Growth, (US$, Mn), 2015-2026
Figure 9. By Type - China Depression Drugs Market Share, 2015-2026
Figure 10. By Application - Depression Drugs Revenue in China (US$, Mn), 2020 & 2026
Figure 11. By Application - China Depression Drugs Market Share, 2015-2026
Figure 12. PEST Analysis for China Depression Drugs Market in 2020
Figure 13. Depression Drugs Market Opportunities & Trends in China
Figure 14. Depression Drugs Market Drivers in China
Global Divalproex Sodium Market Research Report 2024
Published: 08-Jan-2024 Price: US 2900 Onwards Pages: 81
Divalproex Sodium is used to treat certain types of seizures (epilepsy). This medicine is an anticonvulsant that works in The brain tissue to stop seizures.
Divalproex Sodium is also used to treat The manic phase of bipolar disorder (manic-depressive illness), and helps prevent migraine headaches.
This medicine is available only with your doctor's prescription.
The global Divalproex Sodium market was valued at US$ 2188.5 million in 2023 and is anticipated to reach US$ 33......
Global Divalproex Sodium Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 90
According to our LPI (LP Information) latest study, the global Divalproex Sodium market size was valued at US$ 2140.9 million in 2023. With growing demand in downstream market, the Divalproex Sodium is forecast to a readjusted size of US$ 3312 million by 2030 with a CAGR of 6.4% during review period.
The research report highlights the growth potential of the global Divalproex Sodium market. Divalproex Sodium are expected to show stable growth in the future market. However, product differ......
Global Quetiapine Fumarate Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 115
According to our LPI (LP Information) latest study, the global Quetiapine Fumarate market size was valued at US$ 156.2 million in 2023. With growing demand in downstream market, the Quetiapine Fumarate is forecast to a readjusted size of US$ 132.9 million by 2030 with a CAGR of -2.3% during review period.
The research report highlights the growth potential of the global Quetiapine Fumarate market. Quetiapine Fumarate are expected to show stable growth in the future market. However, produ......
Global Clozapine Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 114
According to our LPI (LP Information) latest study, the global Clozapine market size was valued at US$ 341.4 million in 2023. With growing demand in downstream market, the Clozapine is forecast to a readjusted size of US$ 463.4 million by 2030 with a CAGR of 4.5% during review period.
The research report highlights the growth potential of the global Clozapine market. Clozapine are expected to show stable growth in the future market. However, product differentiation, reducing costs, and s......
Global Trazodone Hydrochloride (API) Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 92
According to our LPI (LP Information) latest study, the global Trazodone Hydrochloride (API) market size was valued at US$ million in 2023. With growing demand in downstream market, the Trazodone Hydrochloride (API) is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Trazodone Hydrochloride (API) market. Trazodone Hydrochloride (API) are expected to show stable growth in the future......
Global Trazodone Hydrochloride (API) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
Published: 01-Jan-2024 Price: US 3480 Onwards Pages: 93
According to our (Global Info Research) latest study, the global Trazodone Hydrochloride (API) market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Trazodone, a phenylpiperazine-triazolopyridine antidepressant, was originally discovered and developed in Italy in the 1970s by Angelini research laboratories. Trazodone is used to treat depression and to treat the combination of symptoms of anxiety an......
Global Divalproex Sodium Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
Published: 01-Jan-2024 Price: US 3480 Onwards Pages: 91
According to our (Global Info Research) latest study, the global Divalproex Sodium market size was valued at USD 2251.9 million in 2023 and is forecast to a readjusted size of USD 3371.1 million by 2030 with a CAGR of 5.9% during review period.
Divalproex Sodium is used to treat certain types of seizures (epilepsy). This medicine is an anticonvulsant that works in the brain tissue to stop seizures.
Divalproex Sodium is also used to treat the manic phase of bipolar disorder (manic-d......
Global Risperidone Market Research Report 2023
Published: 28-Dec-2023 Price: US 2900 Onwards Pages: 93
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Risperidone market with multiple angles, which provides sufficient supports to readers' strategy and decision making.
By Company
- Janssen (Johnson & Johnson)
- Ajanta Pharma
- Amneal Pharmaceuticals
- Aurobindo Pharma
- Hikma
- Sandoz
- Lannett
- Tris Pharma
- Ap......
Global Schizophrenia Therapeutics Market Status and Outlook 2023-2028
Published: 27-Dec-2023 Price: US 3160 Onwards Pages: 101
Schizophrenia is usually treated with an individually tailored combination of talking therapy and medicine. Most people with schizophrenia are treated by community mental health teams (CMHTs). The goal of the CMHT is to provide day-to-day support and treatment while ensuring you have as much independence as possible.
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market va......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
